Publications

Detailed Information

EVORPACEPT (ALX148), A CD47 MYELOID CHECKPOINT INHIBITOR, IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) AND WITH GASTRIC/GASTROESOPHAGEAL CANCER (GC); ASPEN-01

Cited 4 time in Web of Science Cited 0 time in Scopus
Authors

Lee, Keun-Wook; Chung, Hyun; Kim, Tae Min; Lakhani, Nehal; Messersmith, Wells; Santana-Davila, Rafael; Kim, Won Seog; LoRusso, Patricia; Bang, Yung-Jue; Chow, Laura; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Forgie, Alison; Wan, Hong; Pons, Jaume; Randolph, Sophia; Gainor, Justin

Issue Date
2021-11
Publisher
BioMed Central
Citation
Journal for ImmunoTherapy of Cancer, Vol.9, pp.A530-A530
ISSN
2051-1426
URI
https://hdl.handle.net/10371/199003
DOI
https://doi.org/10.1136/jitc-2021-SITC2021.498
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share